67 results
Page 2 of 4
8-K
9r621ylxmmbe24h
25 Jul 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
ysg9niuojvuqjspgp
25 Jul 23
Regulation FD Disclosure
7:05am
8-K
EX-99.2
6o22dh
25 Jul 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
xqg1eao 56
4 May 23
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
PRE 14A
cdrolpauwa7
17 Apr 23
Preliminary proxy
4:01pm
S-8
EX-99.1
2u95qf41 cnsyc3
13 Apr 23
Registration of securities for employees
4:02pm
8-K
lw6fp3wc18166vkelik
2 Dec 22
Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a
9:05am
8-K
EX-99.1
ic0h6t berk
2 Dec 22
Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a
9:05am
8-K
EX-99.2
rhmb qyykhfk06jh5f
14 Nov 22
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
noue55ap
14 Nov 22
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
p7x36rqu54y
8 Aug 22
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
noy1it2027q65f11
10 May 22
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am